Julia Riganti
Hospital Italiano de Buenos Aires(AR)
Publications by Year
Research Areas
Autoimmune Bullous Skin Diseases, Urticaria and Related Conditions, Cancer Immunotherapy and Biomarkers, Drug-Induced Adverse Reactions, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement(2021)91 cited
- → Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group(2020)85 cited
- → Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients(2022)38 cited
- → Reactivation of Chagas’ disease: cutaneous manifestations in two immunosuppressed patients(2012)34 cited
- → Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study(2023)26 cited
- → A simple method of infecting rabbits with Bovine herpesvirus 1 and 5(2008)16 cited
- → Pénfigo vulgar: estudio de cohorte retrospectivo de sus características clínicas, tratamientos empleados y evolución(2020)15 cited
- → Secondary syphilis with pulmonary involvement(2015)9 cited
- → Management of human epidermal growth factor receptor inhibitors‐related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process(2024)8 cited
- → Immune Checkpoint Inhibitor–Induced Vitiligo-Like Depigmentation(2024)8 cited